A new study published in the journal of Neurology revealed that semaglutide may increase the risk of non-arteritic anterior ...

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...

Understand how peptides function in the human body, antimicrobial peptides, skin care applications, and regulatory updates.

CDSCO asks SLAs to take strict action against violation of regulations on GLP-1 based weight loss drugs: Gireesh Babu, New Delhi Wednesday, May 20, 2026, 08:00 Hrs [IST] The Centr ...

Specialty trend reached $62.25 PMPM (+11.1%), largely from utilization growth in oncology, immunology, and dermatology; ...

"It was David versus Goliath ... and you know something, we ripped them to shreds." -- Daniel McGee, MD, of Eugene Emergency Physicians in Oregon, a plaintiff in a lawsuit to block an employer from ...

Associate Health Minister David Seymour and Health Minister Simeon Brown welcome Pharmac’s proposal to change funding criteria for three type 2 diabetes medicines based on clinical need. “Improving ...

Pharmac is asking for feedback on proposed changes to the access criteria for some funded medicines used to treat type 2 diabetes. Pharmac is proposing to change who can receive funded treatment with ...

New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 ...

New research presented at this year’s European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new ...

Nephrologists are initiating SGLT2 inhibitors earlier in the chronic kidney disease (CKD) treatment journey and continuing them well below labeled eGFR thresholds. At the same time, real-world uptake ...

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant ...